Controlled PEGylation of periodic mesoporous organosilica nanospheres for improving their stability in physiological solutions

详细信息    查看全文 | 推荐本文 |

英文篇名：Controlled PEGylation of periodic mesoporous organosilica nanospheres for improving their stability in physiological solutions 作者：Xiaodan ; Su ; Jun ; Tao ; Qing ; Wang ; Peng ; Xu ; Wei ; Luo ; Meng ; Dang ; Jiang ; Wu ; Zhaogang ; Teng 英文作者：Xiaodan Su;Jun Tao;Qing Wang;Peng Xu;Wei Luo;Meng Dang;Jiang Wu;Zhaogang Teng;Key Laboratory for Organic Electronics and Information Displays, Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials, Jiangsu National Synergetic Innovation Centre for Advanced Materials, Nanjing University of Posts & Telecommunications;College of Chemical Engineering, Nanjing Forestry University;State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University;Department of Nuclear Medicine, Jinling Hospital, School of Medicine, Nanjing University; 英文关键词：Mesoporous;;Organosilica;;Polyethylene glycol;;Physiological solution;;Stability 中文刊名：FXKB 英文刊名：中国化学快报(英文版) 机构：Key Laboratory for Organic Electronics and Information Displays, Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials, Jiangsu National Synergetic Innovation Centre for Advanced Materials, Nanjing University of Posts & Telecommunications;College of Chemical Engineering, Nanjing Forestry University;State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University;Department of Nuclear Medicine, Jinling Hospital, School of Medicine, Nanjing University; 出版日期：2019-04-15 出版单位：Chinese Chemical Letters 年：2019 期：v.30 基金：financial support from the Natural Science Foundation of Jiangsu Province (Nos. BK20160017 and BK20160610);; the National Natural Science Foundation of China (Nos. 21603106, 51822202 and 51772050);; the State Key Laboratory of Analytical Chemistry for Life Science (No. 5431ZZXM1717);; Shanghai Rising-Star Program (No. 18QA1400100);; Youth Topnotch Talent Support Program of Shanghai;; DHU Distinguished Young Professor Program and Fundamental Research Funds for the Central Universities 语种：英文; 页：FXKB201904022 页数：4 CN：04 ISSN：11-2710/O6 分类号：131-134

摘要

The stability of periodic mesoporous organosilica(PMO) nanoparticles in physiological solutions greatly affects their potential biomedical applications. Herein, thioether-bridged PMO nanospheres with a diameter of 61 nm are synthesized. Then, the thioether-bridged PMO nanospheres are modified with different molecular weighted polyethylene glycol(PEG) via click reaction for the first time. FI-IR and thermogravimetric analysis confirm the successful modification of PEG on the PMO. The influence of PEG molecular weight on the dispersity and stability of the PMO-PEG in phosphate buffer(PBS) and Dulbecco's modified Eagle's medium(DMEM) is studied. The results show that the PEG coating increases the stability and dispersity of PMO in the biological solutions. The PMO-PEG1K, PMO-PEG2K, and PMOPEG5K have better stability in PBS solution. The PMO-PEG2K shows best stability and dispersity in DMEM. Over all, this work provides important method and knowledge to guide the modification of PMO for biomedical applications
        The stability of periodic mesoporous organosilica(PMO) nanoparticles in physiological solutions greatly affects their potential biomedical applications. Herein, thioether-bridged PMO nanospheres with a diameter of 61 nm are synthesized. Then, the thioether-bridged PMO nanospheres are modified with different molecular weighted polyethylene glycol(PEG) via click reaction for the first time. FI-IR and thermogravimetric analysis confirm the successful modification of PEG on the PMO. The influence of PEG molecular weight on the dispersity and stability of the PMO-PEG in phosphate buffer(PBS) and Dulbecco's modified Eagle's medium(DMEM) is studied. The results show that the PEG coating increases the stability and dispersity of PMO in the biological solutions. The PMO-PEG1K, PMO-PEG2K, and PMOPEG5K have better stability in PBS solution. The PMO-PEG2K shows best stability and dispersity in DMEM. Over all, this work provides important method and knowledge to guide the modification of PMO for biomedical applications

引文

[1]Z.G.Teng,X.D.Su,Y.Zheng,et al.,Chem.Mater.25(2013)98-105.
    [2]Z.G.Teng,X.D.Su,B.H.Lee,et al.,Chem.Mater.26(2014)5980-5987.
    [3]Z.G.Teng,J.J.Zhang,W.Li,et al.,Small 12(2016)3550-3558.
    [4]J.Tao,M.Dang,X.D.Su,et al.,J.Colloid.Interf.Sci.527(2018)33-39.
    [5]Y.Chen,J.L.Shi,Adv.Mater.28(2016)3235-3272.
    [6]F.Hoffmann,M.Cornelius,J.Morell,M.Froba,Angew.Chem.Int.Ed.45(2006)3216-3251.
    [7]J.G.Croissant,X.Catto?n,M.W.C.Man,et al.,Nanoscale 7(2015)20318-20334.
    [8]J.G.Croissant,Y.Fatieiev,H.Omar,et al.,Chem.Eur.J.22(2016)1-10.
    [9]X.R.Zhou,X.W.Cheng,Y.H.Zhu,et al.,Chin.Chem.Lett.29(2018)405-416.
    [10]L.Yu,W.L.Liu,Z.F.Zhang,Z.T.Song,Chin.Chem.Lett.26(2015)700-704.
    [11]P.Han,T.C.Liu,X.W.Ji,S.K.Tang,Chin.Chem.Lett.29(2018)1305-1309.
    [12]J.T.Dai,Y.Zhang,H.C.Lia,et al.,Chin.Chem.Lett.28(2017)531-536.
    [13]J.Wei,Y.Ren,W.Luo,et al.,Chem.Mater.29(2017)2211-2217.
    [14]J.Wei,Z.K.Sun,W.Luo,et al.,J.Am.Chem.Soc.139(2017)1706-1713.
    [15]G.Wang,J.Qin,X.R.Zhou,et al.,Adv.Funct.Mater.28(2018)[35_TD$IF]21806144.
    [16]Y.Rui,X.M.Wu,B.D.Ma,et al.,Chin.Chem.Lett.29(2018)1387-1390.
    [17]P.Han,T.C.Liu,X.W.Ji,et al.,Chin.Chem.Lett.29(2018)1305-1309.
    [18]A.Salvati,A.S.Pitek,M.P.Monopoli,et al.,Nat.Nanotechnol.8(2013)137-143.
    [19]A.E.Nel,L.M?dler,D.Velegol,et al.,Nat.Mater.8(2009)543-557.
    [20]T.Cedervall,I.Lynch,S.Lindman,et al.,Proc.Natl.Acad.Sci.U.S.A.104(2007)2050-2055.
    [21]X.Du,F.Kleitz,X.Y.Li,Adv.Funct.Mater.28(2018)[38_TD$IF]21707325.
    [22]R.Gref,M.Luck,P.Quellec,et al.,Colloids Surf.B Biointerfaces 18(2000)301-313.
    [23]P.Aggarwal,J.B.Hall,C.B.McLeland,et al.,Adv.Drug Deliver.Rev.61(2009)428-437.
    [24]T.A.Horbett,Cardiovasc.Pathol.2(1993)137-148.
    [25]G.Prencipe,S.M.Tabakman,K.Welsher,et al.,J.Am.Chem.Soc.131(2009)4783-4787.
    [26]N.Mizoshita,T.Tani,S.Inagaki,Chem.Soc.Rev.40(2011)789-800.
    [27]X.Duan,Y.P.Li,Small 9(2013)1521-1532.
    [28]P.Huang,Y.Chen,H.Lin,et al.,Biomaterials 125(2017)23-37.
    [29]M.Y.Wu,Q.S.Meng,Y.Chen,et al.,Adv.Mater.27(2015)215-222.
    [30]N.Lu,Y.Tian,W.Tian,et al.,ACS Appl.Mater.Interfaces 8(2016)2985-2993.
    [31]H.Otsuka,Y.Nagasaki,K.Kataoka,Adv.Drug Deliver.Rev.64(2012)246-255.
    [32]Z.G.Teng,C.Y.Wang,Y.X.Tang,et al.,J.Am.Chem.Soc.140(2018)1385-1393.
    [33]G.S.Irmukhametova,B.J.Fraser,J.L.Keddie,et al.,Langmuir 28(2012)299-306.